Module 5 unit C Flashcards

(31 cards)

1
Q

Ergot alkaloids

A

Dihydroergotamine

Ergotamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA of ergotamine

A

Alters transmission at serotonergic, dopaminergic & a-adrenergic junctions. Vasconstrictor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ergot alkaloid indications

dihydroergotamine, ergotamine

A

Acute treatment of migraines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Triptan

A

Sumatriptan (Imitrex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Indications of Triptans

A

Acute abortive treatment of migraines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA of triptans

A

Selective activation of 5HT receptors-suppresses the release of CGRP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BBW for Ergot alkaloids

A

Potent inhibitors of CYP34A. Risk of vasospasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Are ergot alkaloids okay for pregnancy?

A

No - contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Abortive migraine treatments

A
Triptans
Ergot alkaloids
Ditan
Oral CGRP receptor antagonist (Ubrelvy)
Analgesics (opioids, NSAIDs, APAP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ergot alkaloids contraindications

A

pregnancy (can cause contractions & abortion)
Do not use with triptans
Do not use in renal or liver impairment, CAD, PVD, and uncontrolled HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Oral CGRP receptor antagonist (acute treatment for HDA)

A

Ditan (Reyvow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA of Ditan (Reyvow)

A

Activates 5HT1F receptor agonist - inhibits the release of neuropeptides, neurotransmitters, and inhibits the pain pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ditan safety

A

Schedule V controlled substance, CNS depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

preventive (prophylactic) treatment for migraine headaches

A
Beta Blockers
TCAs
AEDs (Depakote)
Botox
CGRP monoclonal antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment for migraine headaches given by injection monthly

A

CGRP monoclonal antibodies

Erenumab (Aimovig)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MOA of Botox

A

Prevents release of acetylcholine at neuromuscular junctions

17
Q

MOA of Depakote

A

May augment inhibitory effects of GABA

18
Q

Safety with Depakote

A

Contraindicated in pregnancy

19
Q

BBW with Depakote

A

Potentially fatal pancreatitis and hepatitis Neural tube defects in developing fetus.

20
Q

Used for acute gout attacks

A

NSAIDs, Interleukin-1 inhibitors, glucocorticoids, colchicine

21
Q

used for prevention of gout

A

colchicine
urate-lowering therapy
xanthine oxidase inhibitors (allopurinol), uricosuric agent (probenecid),
recombinant uric acid oxidase (pegloticase)

22
Q

Three FDA approved drugs for fibromyalgia

A

Milnacipran
Duloxetine
pregabalin

23
Q

SNRIs for fibromyalgia

A

Milnacipran (Savella)

Duloxetine (cymbalta)

24
Q

MOA for duloxetine and milnacipran

A

Boost serotonin and norepinephrine

25
Anticonvulsants for fibromyalgia
pregabalin (Lyrica) - grade A | Gabapentin - Grade B
26
Can cause rhabdomyolysis, especially if the patient is on a statin
colchicine
27
Helps degrade tophi in gout | Inhibits enzyme required for uric acid formation (xanthine)
allopurinol
28
Lowers plasma urate levels by increasing iexcretion of uric acid
probenecid
29
risk of renal stones
probenecid
30
Warning for pegloticase
Do not give to patients with G6PD deficiency - can cause hemolysis and methemoglobinemia
31
problem with muscle relaxants
Cause CNS sedation | Increase risk of falls and injury